Ignite Creation Date:
2024-05-06 @ 3:14 PM
Last Modification Date:
2024-10-26 @ 1:45 PM
Study NCT ID:
NCT04562129
Status:
RECRUITING
Last Update Posted:
2024-07-08
First Post:
2020-09-18
Brief Title:
IL2 With Ipilimumab Followed by Nivolumab in Stage 3 or 4 Melanoma Patients
Sponsor:
H Lee Moffitt Cancer Center and Research Institute
Organization:
H Lee Moffitt Cancer Center and Research Institute
Conditions & Keywords Data
Conditions:
| Name |
|---|
| Inoperable Disease |
| Melanoma Stage III |
| Melanoma Stage IV |
Keywords:
| Name | View |
|---|---|
| skin cancer | View |